BindingDB logo
myBDB logout

null

SMILES: FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCCC2=O)cc1

InChI Key: InChIKey=SVOPHBAOQBWPQY-HXUWFJFHSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 497393   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
fMet-Leu-Phe receptor


(Homo sapiens (Human))
BDBM497393
PNG
(US11008301, Example 4)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCCC2=O)cc1 |r|
Show InChI InChI=1S/C24H25F3N4O3/c25-24(26,27)16-6-8-17(9-7-16)28-23(34)29-20-4-3-15-31(22(20)33)19-12-10-18(11-13-19)30-14-2-1-5-21(30)32/h6-13,20H,1-5,14-15H2,(H2,28,29,34)/t20-/m1/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 410n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)


BindingDB Entry DOI: 10.7270/Q2HX1GTH
More data for this
Ligand-Target Pair
N-formyl peptide receptor 2


(Homo sapiens (Human))
BDBM497393
PNG
(US11008301, Example 4)
Show SMILES FC(F)(F)c1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)N2CCCCC2=O)cc1 |r|
Show InChI InChI=1S/C24H25F3N4O3/c25-24(26,27)16-6-8-17(9-7-16)28-23(34)29-20-4-3-15-31(22(20)33)19-12-10-18(11-13-19)30-14-2-1-5-21(30)32/h6-13,20H,1-5,14-15H2,(H2,28,29,34)/t20-/m1/s1
PDB

NCI pathway
Reactome pathway
KEGG

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/an/an/a 28n/an/an/an/a



Bristol-Myers Squibb Company

US Patent


Assay Description
FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...


US Patent US11008301 (2021)


BindingDB Entry DOI: 10.7270/Q2HX1GTH
More data for this
Ligand-Target Pair